Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Market Cap 2006-2020 | GILD

Gilead Sciences market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Gilead Sciences market cap as of August 06, 2020 is $86.55B.
  
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $86.552B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.427B 15.36
Bristol Myers Squibb (BMY) United States $135.060B 11.28
CSL (CSLLY) Australia $90.565B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.167B 39.71
Regeneron Pharmaceuticals (REGN) United States $68.708B 25.41
Illumina (ILMN) United States $58.909B 60.53
Biogen (BIIB) United States $43.721B 7.48
Seattle Genetics (SGEN) United States $28.290B 0.00
Moderna (MRNA) United States $28.139B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.830B 0.00
Genmab (GMAB) Denmark $23.636B 19.45
Alexion Pharmaceuticals (ALXN) United States $22.520B 9.38
Genmab (GNMSF) Denmark $22.474B 66.72
BioMarin Pharmaceutical (BMRN) United States $21.670B 157.67
Incyte (INCY) United States $21.349B 0.00
BeiGene (BGNE) Cayman Islands $20.285B 0.00
BioNTech SE (BNTX) Germany $18.395B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.354B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.565B 70.47
Horizon Therapeutics Public (HZNP) Ireland $14.572B 36.90
Exact Sciences (EXAS) United States $13.806B 0.00
Galapagos (GLPG) Belgium $12.518B 36.82
Sarepta Therapeutics (SRPT) United States $12.392B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.879B 0.00
QIAGEN (QGEN) Netherlands $10.725B 27.22
Immunomedics (IMMU) United States $10.247B 0.00
Bio-Techne Corp (TECH) United States $10.239B 70.86
Novavax (NVAX) United States $10.055B 0.00
Repligen (RGEN) United States $8.184B 129.90
Guardant Health (GH) United States $8.045B 0.00
Ascendis Pharma (ASND) Denmark $7.861B 0.00
Emergent Biosolutions (EBS) United States $7.116B 28.19
Exelixis (EXEL) United States $7.068B 24.78
ACADIA Pharmaceuticals (ACAD) United States $6.682B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.632B 205.46
SWEDISH ORP BIO (BIOVF) Sweden $6.351B 15.80
Vir Biotechnology (VIR) United States $5.972B 0.00
Acceleron Pharma (XLRN) United States $5.735B 0.00
Mirati Therapeutics (MRTX) United States $5.477B 0.00
MyoKardia (MYOK) United States $5.299B 0.00
Adaptive Biotechnologies (ADPT) United States $5.106B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.057B 0.00
Reata Pharmaceuticals (RETA) United States $5.032B 0.00
Zai Lab (ZLAB) China $4.718B 0.00
MorphoSys AG (MOR) Germany $4.570B 35.45
NeoGenomics (NEO) United States $4.453B 1344.00
China Biologic Products (CBPO) China $4.219B 23.45
Blueprint Medicines (BPMC) United States $4.185B 0.00
Global Blood Therapeutics (GBT) United States $4.138B 0.00
Halozyme Therapeutics (HALO) United States $3.941B 0.00
Amicus Therapeutics (FOLD) United States $3.891B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.849B 0.00
Bluebird Bio (BLUE) United States $3.454B 0.00
Inovio Pharmaceuticals (INO) United States $3.445B 0.00
Sorrento Therapeutics (SRNE) United States $3.336B 0.00
Arena Pharmaceuticals (ARNA) United States $3.243B 0.00
Alkermes (ALKS) Ireland $2.980B 62.47
Principia Biopharma (PRNB) United States $2.976B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.729B 0.00
Twist Bioscience (TWST) United States $2.723B 0.00
Insmed (INSM) United States $2.706B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Fate Therapeutics (FATE) United States $2.551B 0.00
Denali Therapeutics (DNLI) United States $2.455B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
Ligand Pharmaceuticals (LGND) United States $1.869B 63.29
UniQure (QURE) Netherlands $1.859B 0.00
Mesoblast (MESO) Australia $1.837B 0.00
Viela Bio (VIE) United States $1.807B 0.00
Editas Medicine (EDIT) United States $1.794B 0.00
I-Mab (IMAB) China $1.672B 0.00
Sangamo Therapeutics (SGMO) United States $1.620B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.610B 0.00
Eidos Therapeutics (EIDX) United States $1.598B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.583B 0.00
Adverum Biotechnologies (ADVM) United States $1.461B 0.00
Zymeworks (ZYME) Canada $1.424B 0.00
Zealand Pharma (ZEAL) Denmark $1.397B 0.00
Mersana Therapeutics (MRSN) United States $1.393B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.386B 0.00
Revance Therapeutics (RVNC) United States $1.376B 0.00
Intra-Cellular Therapies (ITCI) United States $1.376B 0.00
Epizyme (EPZM) United States $1.322B 0.00
Cytokineticsorporated (CYTK) United States $1.316B 0.00
NGM Biopharmaceuticals (NGM) United States $1.310B 0.00
Coherus BioSciences (CHRS) United States $1.288B 8.99
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
REGENXBIO (RGNX) United States $1.273B 0.00
Arvinas (ARVN) United States $1.203B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.180B 0.00
Alcobra (ARCT) United States $1.157B 0.00
Alector (ALEC) United States $1.152B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.135B 0.00
Compugen (CGEN) Israel $1.117B 0.00
Akcea Therapeutics (AKCA) United States $1.100B 0.00
Beam Therapeutics (BEAM) United States $1.096B 0.00
NantKwest (NK) United States $1.073B 0.00
VBI Vaccines (VBIV) United States $1.042B 0.00
Heska (HSKA) United States $1.011B 0.00
Intellia Therapeutics (NTLA) United States $1.010B 0.00
Retrophin (RTRX) United States $0.985B 0.00
Arcus Biosciences (RCUS) United States $0.979B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Athenex (ATNX) United States $0.931B 0.00
Myriad Genetics (MYGN) United States $0.929B 47.92
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.871B 0.00
Intrexon (PGEN) United States $0.842B 0.00
Dynavax Technologies (DVAX) United States $0.829B 0.00
Cara Therapeutics (CARA) United States $0.805B 0.00
Codexis (CDXS) United States $0.760B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Morphic Holding (MORF) United States $0.746B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
Castle Biosciences (CSTL) United States $0.726B 0.00
Vericel (VCEL) United States $0.718B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.705B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.676B 0.00
Frequency Therapeutics (FREQ) United States $0.669B 0.00
MiMedx (MDXG) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.601B 5.27
Biofrontera AG (BFRA) Germany $0.601B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.592B 0.00
Cue Biopharma (CUE) United States $0.583B 0.00
Agenus (AGEN) United States $0.573B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.537B 0.00
IBio (IBIO) United States $0.520B 0.00
Syros Pharmaceuticals (SYRS) United States $0.515B 0.00
Athersys (ATHX) United States $0.513B 0.00
Kala Pharmaceuticals (KALA) United States $0.500B 0.00
Clovis Oncology (CLVS) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.491B 0.00
Prothena (PRTA) Ireland $0.490B 0.00
Innate Pharma S.A (IPHA) France $0.489B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
Anika Therapeutics (ANIK) United States $0.484B 21.17
Orchard Therapeutics (ORTX) United Kingdom $0.476B 0.00
UROGEN PHARMA (URGN) United States $0.470B 0.00
Cel-Sci (CVM) United States $0.462B 0.00
Protagonist Therapeutics (PTGX) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.444B 0.00
BioDelivery Sciences (BDSI) United States $0.436B 31.11
Puma Biotechnology (PBYI) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Prometic Life Sciences (LMNL) Canada $0.417B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.408B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Kamada (KMDA) Israel $0.398B 16.56
MannKind (MNKD) United States $0.396B 0.00
Scholar Rock Holding (SRRK) United States $0.395B 0.00
Merus (MRUS) Netherlands $0.391B 0.00
PDL BioPharma (PDLI) United States $0.383B 336.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.43
Albireo Pharma (ALBO) United States $0.362B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.356B 0.00
Precision BioSciences (DTIL) United States $0.352B 0.00
Geron (GERN) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Seres Therapeutics (MCRB) United States $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.322B 0.00
ChromaDex (CDXC) United States $0.316B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
Menlo Therapeutics (MNLO) United States $0.309B 0.00
ADMA Biologics Inc (ADMA) United States $0.307B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.294B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
Trevena (TRVN) United States $0.282B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
DBV Technologies S.A (DBVT) France $0.272B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.270B 0.00
Pfenex (PFNX) United States $0.269B 0.00
NextCure (NXTC) United States $0.267B 0.00
Celldex Therapeutics (CLDX) United States $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.252B 0.00
Northwest Biotherapeutics (NWBO) United States $0.249B 0.00
Verastem (VSTM) United States $0.249B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Selecta Biosciences (SELB) United States $0.243B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Dyadic (DYAI) United States $0.237B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
HOOKIPA Pharma (HOOK) United States $0.229B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 9.60
Sutro Biopharma (STRO) United States $0.196B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.194B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
XOMA (XOMA) United States $0.184B 0.00
Cerecor (CERC) United States $0.183B 0.00
Aptinyx (APTX) United States $0.178B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.171B 0.00
Liquidia Technologies (LQDA) United States $0.170B 0.00
Bellus Health (BLU) Canada $0.168B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Cidara Therapeutics (CDTX) United States $0.165B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Cyclerion Therapeutics (CYCN) United States $0.151B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
Kindred Biosciences (KIN) United States $0.147B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
Eton Pharmaceuticals (ETON) United States $0.144B 0.00
VolitionRX (VNRX) United States $0.142B 0.00
Applied Genetic Technologies (AGTC) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.133B 3.41
Lineage Cell Therapeutics (LCTX) United States $0.131B 0.00
Checkpoint Therapeutics (CKPT) United States $0.130B 0.00
Gritstone Oncology (GRTS) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 0.00
Oncobiologics (OTLK) United States $0.122B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
Cardiff Oncology (CRDF) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.115B 0.00
CorMedix Inc (CRMD) United States $0.113B 0.00
Vaccinex (VCNX) United States $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.105B 0.00
AquaBounty Technologies (AQB) United States $0.102B 0.00
Organovo Holdings (ONVO) United States $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.086B 0.00
Unum Therapeutics (UMRX) United States $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Soligenix (SNGX) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Bionano Genomics (BNGO) United States $0.063B 0.00
AnPac Bio-Medical Science (ANPC) China $0.063B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
IMMURON (IMRN) Australia $0.061B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
Curis (CRIS) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prana Biotechnology (ATHE) Australia $0.042B 0.00
Spherix (AIKI) United States $0.041B 0.00
Celsion (CLSN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.038B 0.00
OvaScience (MLND) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.031B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
MYOS RENS Technology (MYOS) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00